ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Dutasterid-Tamsulosin-Mepha 0.5 mg/0.4 mg, Kapseln - 7
66798001 Mepha Pharma AG
Dutasterid-Tamsulosin-Mepha 0.5 mg/0.4 mg, Kapseln12.09.2018
Generic12.09.2018
Tamsulosin and Dutasteride (G04CA52) 
WHO-DDD 
05.99.7
05.99. 
B  
Yes 
IPCI
3.71No
    
10 %8.35
  
7680667980018Synthetika
7618341 
Composition
dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, E 321, gelatina, glycerolum, E 171, acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, Kapselhülle: gelatina, E 171, E 172 (nigrum), E 172 (rubrum), E 172 (flavum), Drucktinte: propylenglycolum, lacca, E 172 (nigrum), ammoniae solutio concentrata, kalii hydroxidum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Dutasteride0.5 mg
Tamsulosine Hydrochloride0.4 mg correspond Tamsulosinum 0.367 mg
BAG: Active AgentDose
Dutasteride0.5 mg
Tamsulosine Hydrochloride0.4 mg
 
Inactive agents additional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Acidi Methacrylici  
Ammoniae Solutio Concentrata  
Calcii Stearas  
Cellulosum Microcristallinum  
Dibutylis Sebacas  
E 171 color.
E 172 color.
E 321  
Ethylis Acrylatis Polymerisatum cum Polysorbatum 80  
Gelatina Kapselhülle
Glycerol  
Kalii Hydroxidum  
Lacca  
Natrii Laurilsulfas  
Pro Capsula  
Propylenglycoli Monooctanoas  
Propylenglycol Drucktinte
Silica Colloidalis Hydrica  
 
Source
Data was imported : 07.02.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home